TA Associates’ $2.3 Billion Acquisition Of Smiths Medical

McDermott Will & Emery advised TA Associates on the deal. White & Case Advised Smiths Group plc.

TA Associates (TA), a leading global growth private equity firm, entered into a definitive agreement for the $2.3 billion acquisition of Smiths Medical, the medical devices and technologies business of the Smiths Group plc. The acquisition is conditional upon the approval of Smiths’ shareholders and on receipt of certain anti-trust regulatory approvals.

Smiths Medical is a leading global manufacturer of specialty medical devices and technologies with key franchises in infusion systems, vascular access and vital care. The company is headquartered in Minneapolis, Minnesota, with operations in more than 30 countries, and employs more than 7,500 employees.

TA is one of the most experienced global growth private equity firms. It has more than 50 years of experience helping to scale companies in targeted sectors within its five core industries of technology, healthcare, financial services, consumer and business services. TA invests in profitable, growing companies with opportunities for sustained growth. Since its founding, TA has raised $47.5 billion in capital and has invested in more than 535 companies around the world.

The cross-border McDermott team was led by corporate attorney Arvin Abraham (Picture) and included partners Tom Whelan, Linda Zeman, James Ross and Paul McGrath, supported by  counsel Philip Corser along with associates Emmy Clode, Antonina Nijran, Sarah Gabbai, Rosie Mist, and trainee solicitors Simon Margesson and Bethany Drayton. In Paris, partner Jilali Maazouz and associate Abdel Abdellah and partner Heather Bethancourt in Dallas also advised.

The White & Case team which advised on the transaction was led by Guy Potel and Richard Jones (both London), with support from partners Gregory Pryor and Suni Sreepada (both New York), Lindsey Canning, Peita Menon, Colin Harley and Marc Israel (all London), George Paul (Washington, DC) and Alexandre Jaurett (Paris), counsel Paul Harrington (London) and associates Omar Anwar, Finlay Fraser, Claire Sackman, Kal Leung, Amy Detheridge, Oliver Trotman and Kate Kelliher (all London), and Cecilia Grosjean (Paris).

Involved fees earner: Abdel Abdellah – McDermott Will & Emery; Arvin Abraham – McDermott Will & Emery; Heather Bethancourt – McDermott Will & Emery; Emmy Clode – McDermott Will & Emery; Philip Corser – McDermott Will & Emery; Sarah Gabbai – McDermott Will & Emery; Jilali Maazouz – McDermott Will & Emery; Paul McGrath – McDermott Will & Emery; Rosie Mist – McDermott Will & Emery; Antonina Nijran – McDermott Will & Emery; James Ross – McDermott Will & Emery; Tom Whelan – McDermott Will & Emery; Linda Zeman – McDermott Will & Emery; Omar Anwar – White & Case; Lindsey Canning – White & Case; Amy Detheridge – White & Case; Finlay Fraser – White & Case; Cécilia Grosjean – White & Case; Colin Harley – White & Case; Paul Harrington – White & Case; Marc Israel – White & Case; Alexandre Jaurett – White & Case; Richard Jones – White & Case; Kate Kelliher – White & Case; Kal Leung – White & Case; Peita Menon – White & Case; George Paul – White & Case; Guy Potel – White & Case; Gregory Pryor – White & Case; Claire Sackman – White & Case; Suni Sreepada – White & Case; Oliver Trotman – White & Case;

Law Firms: McDermott Will & Emery; White & Case;

Clients: Smiths Group plc; TA Associates;

Author: Federica Tiefenthaler